Viewing Study NCT01626794


Ignite Creation Date: 2025-12-25 @ 1:38 AM
Ignite Modification Date: 2025-12-31 @ 2:23 PM
Study NCT ID: NCT01626794
Status: WITHDRAWN
Last Update Posted: 2015-01-27
First Post: 2012-06-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Immunogenicity, Safety, and Tolerability of VARIVAX™ Manufactured With a New Process (V210-062)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module